Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PurTox for Glabellar Rhytides
NCT00752258Phase 3Completed
- Sponsor
- Mentor Worldwide
- Start
- Feb 2008
- Primary completion
- May 2011
- Countries
- 1
01
Overview
Phase 3, open-label trial of botulinum toxin type A in glabellar rhytides, sponsored by Mentor Worldwide. Primary endpoint: Treatment-Emergent Adverse Events. Started Feb 2008; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar rhytides
Beyond the preview
Go deeper on NCT00752258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00752258.